Cargando…
Drug–nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3)
BACKGROUND: Transporter-mediated drug–nutrient interactions have the potential to cause serious adverse events. However, unlike drug–drug interactions, these drug–nutrient interactions receive little attention during drug development. The clinical importance of drug–nutrient interactions was highlig...
Autores principales: | Vora, Bianca, Green, Elizabeth A E, Khuri, Natalia, Ballgren, Frida, Sirota, Marina, Giacomini, Kathleen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944527/ https://www.ncbi.nlm.nih.gov/pubmed/31764942 http://dx.doi.org/10.1093/ajcn/nqz255 |
Ejemplares similares
-
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2
por: Enogieru, Osatohanmwen J., et al.
Publicado: (2021) -
The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the Mouse
por: Wen, Anita, et al.
Publicado: (2023) -
Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data
por: Yee, Sook Wah, et al.
Publicado: (2021) -
The SLC transporter in nutrient and metabolic sensing, regulation, and drug development
por: Zhang, Yong, et al.
Publicado: (2018) -
Genetic Variations in Thiamin Transferase SLC35F3 and the Risk of Hypertension in Koreans
por: Seo, Ja-young, et al.
Publicado: (2021)